The role of busulfan/cyclophosphamide regimens in allogeneic and autologous bone marrow transplantation

Cancer Invest. 1989;7(5):509-13. doi: 10.3109/07357908909041380.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Bone Marrow Transplantation*
  • Busulfan / administration & dosage*
  • Cyclophosphamide / administration & dosage*
  • Graft vs Host Disease / prevention & control
  • Humans
  • Leukemia, Myeloid, Acute / therapy
  • Lymphoma / therapy
  • Mice
  • Rats
  • Transplantation, Autologous
  • Transplantation, Homologous

Substances

  • Cyclophosphamide
  • Busulfan